chr8-144516608-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000621189.4(RECQL4):c.-561C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000137 in 1,610,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000621189.4 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000197  AC: 3AN: 152224Hom.:  0  Cov.: 34 show subpopulations 
GnomAD2 exomes  AF:  0.0000247  AC: 6AN: 242568 AF XY:  0.0000226   show subpopulations 
GnomAD4 exome  AF:  0.0000130  AC: 19AN: 1458360Hom.:  0  Cov.: 35 AF XY:  0.0000165  AC XY: 12AN XY: 725354 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000197  AC: 3AN: 152224Hom.:  0  Cov.: 34 AF XY:  0.00  AC XY: 0AN XY: 74362 show subpopulations 
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
- -
Baller-Gerold syndrome    Uncertain:1 
This sequence change replaces arginine with tryptophan at codon 171 of the RECQL4 protein (p.Arg171Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs775651175, gnomAD 0.006%). This missense change has been observed in individual(s) with breast cancer (PMID: 28076423). ClinVar contains an entry for this variant (Variation ID: 407019). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
RECQL4-related disorder    Uncertain:1 
The RECQL4 c.511C>T variant is predicted to result in the amino acid substitution p.Arg171Trp. This variant has been reported in an individual with breast cancer and was also observed in this individual's unaffected family members (S2 Table, Kim et al. 2017. PubMed ID: 28076423). This variant is reported in 0.0058% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/8-145741992-G-A) and is interpreted as uncertain significance in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/407019/?new_evidence=false). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at